Skip to main content

Table 2 Incidence of adverse events

From: Effects of parecoxib on analgesia benefit and blood loss following open prostatectomy: a multicentre randomized trial

 

Parecoxib (n=52)

Placebo (n=53)

p-value (Parecoxib vs. Placebo)

Anemia

6 (12)

4 (8)

0.53

Vertigo

0 (0)

3 (6)

0.24

Abdominal pain

3 (6)

1 (2)

0.36

Constipation

2 (4)

7 (13)

0.16

Diarrhea

4 (8)

8 (15)

0.36

Flatulence

6 (12)

10 (19)

0.42

Nausea

12 (23)

16 (30)

0.51

Vomiting

9 (17)

4 (8)

0.15

Pyrexia

1 (2)

4 (8)

0.36

Urinary tract infection

8 (15)

7 (13)

0.79

Wound infection

2 (4)

3 (6)

1.0

Back pain

2 (4)

0 (0)

0.24

Hypokaliemia

2 (4)

2 (4)

1.0

Dizziness

2 (4)

2 (4)

1.0

Paresthesia

2 (4)

2 (4)

0.24

Confusion

0 (0)

2 (4)

0.5

Insomnia

3 (6)

1 (2)

0.36

Bladder pain

0 (0)

2 (4)

0.5

Urinary retention

2 (4)

1 (2)

0.62

Cough

1 (2)

2 (4)

1.0

Oropharyngeal pain

3 (6)

2 (4)

0.68

Deep vein thrombosis

2 (4)

0 (0)

0.24

Hypertension

6 (12)

4 (8)

0.53

Hypotension

2 (4)

0 (0)

0.24

Lymphocele

6 (12)

2 (4)

0.16

  1. There were no differences in the incidence of adverse events between parecoxib and placebo. Results are given as numbers (%) of patients reporting an adverse event.
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us